{
    "title": "AstraZeneca sees higher 2022 sales even as COVID boost wanes",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10497323/AstraZeneca-sees-2022-growth-dividend-rises-COVID-boost-falls.html",
    "date": "2022-02-10",
    "keywords": [
        "vaccine",
        "year",
        "covid19",
        "company",
        "percentage",
        "pushkala",
        "aripaka",
        "burger",
        "dividend",
        "forecast",
        "cancer",
        "decline",
        "shot",
        "drug",
        "profit",
        "basis",
        "core",
        "share",
        "pfizer",
        "approval",
        "soriot",
        "time",
        "decade",
        "thursday",
        "kidney",
        "disease",
        "booster",
        "work",
        "omicron",
        "coronavirus",
        "variant",
        "evusheld",
        "competition",
        "astrazeneca",
        "deal",
        "oxford",
        "university",
        "gmt",
        "index",
        "performance",
        "investor",
        "anxiety",
        "guidance",
        "issuance",
        "consensus",
        "back",
        "update",
        "overhang",
        "jp",
        "morgan",
        "note",
        "bestselling",
        "product",
        "lung",
        "tagrisso",
        "moderna",
        "chadox1",
        "ncov19",
        "covishield",
        "weapon",
        "pandemic",
        "use",
        "europe",
        "modernas",
        "role",
        "welcome",
        "reception",
        "latin",
        "america",
        "asia",
        "east",
        "world",
        "half",
        "timetable",
        "growth",
        "trajectory",
        "blockbuster",
        "threshold",
        "revenue",
        "constantcurrency",
        "eps",
        "reporting",
        "bengaluru",
        "ludwig",
        "frankfurt",
        "josephine",
        "mason",
        "editing",
        "jason",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}